Share capital (Details Narrrative) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|
Nov. 07, 2025 |
Aug. 11, 2025 |
May 25, 2022 |
Feb. 17, 2021 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Sep. 30, 2025 |
|
| Share capital | |||||||||
| Description of share capital plan | exercised by the investors at the price of CDN 5.30. As a result, the Company received US $255 in total proceeds. Fair valuation was done under Black Scholes model and the assumptions on the date of exercise included Share price CDN 7.54, Risk-free interest rate (based on U.S. government bond yields) of 2.42%, expected volatility of the market price of shares (based on historical volatility of share price) of 72.30%, and the expected warrant life (in years) of 0 years. A revaluation gain of $35 was recognized in finance cost and $109 were transferred from derivative liability to share capital | exercised by the investors at the price of CDN 5.30. As a result, the Company received US $3,249 in total proceeds. Fair valuation was done under Black Scholes model and the assumptions on the date of exercise included Risk-free interest rate (based on U.S. government bond yields) of 2.68%, expected volatility of the market price of shares (based on historical volatility of share price) of 65.05%, and the expected warrant life (in years) of 0.24 years | exercised 1,420,000 warrants at an exercise price of Cdn $0.90 per share. As a result, the Company issued 1,420,000 common shares and increased its issued and outstanding share capital accordingly. Accordingly, an amount of $4,725 is reclassed from warrants to share capital as presented in condensed interim consolidated statements of changes in equity | ||||||
| Common share issued | 5,405,000 | 5,951,250 | 5,405,000 | 5,951,250 | |||||
| Change in derivative warrant liability | $ 0 | $ 40,000 | $ 0 | $ 40,000 | |||||
| Share issued price | $ 4.862 | $ 2.15 | $ 4.862 | $ 2.15 | |||||
| Equity raise amount | $ 26,079,000 | $ 11,789,000 | $ 26,079,000 | $ 11,789,000 | |||||
| Share issuance cost | $ 207 | ||||||||
| Stock Option increased share | 6,000,000 | 4,600,000 | |||||||
| Outstanding options | 4,700,000 | 4,700,000 | |||||||
| Derivative warrants shares | 0 | 0 | 67,841 | ||||||
| Risk-free interest rate | 2.62% | ||||||||
| Expected volatility | 53.46% | ||||||||
| Expected warrant life | 4 months 9 days | ||||||||
| Stock-based compensation expense | $ 2,382,000 | $ 543,000 | $ 2,781,000 | $ 1,246,000 | |||||
| Stock Option increased share | 4,600,000 | 3,020,000 | |||||||
| Outstanding options | 23,500,000 | 23,500,000 | |||||||